V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund 13F holdings
Dodge & Cox Stock Fund's Portfolio
- Portfolio value:
- $98.89B≈
- # of securities:
- 76
- Reported for:
- 31 Mar 2022 (Q1)
- Latest filing date:
- 26 May 2022
What stocks did Dodge & Cox Stock Fund own in 2022 Q1?
What was Dodge & Cox Stock Fund's 2022 Q1 portfolio?
Dodge & Cox Stock Fund has disclosed a total of 76 security holdings in their (2022 Q1) SEC filing(s) with portfolio value of $98,894,746,179.
Dodge & Cox Stock Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Dodge & Cox Stock Fund's original SEC reports (2022 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
75 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
4.13%
|
48,399,300
|
$84.31
|
+28.07%($107.98)
|
$4,080,544,983
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
|
|
|
|
|
Wells Fargo & Company
|
3.93%
|
80,136,241
|
$48.46
|
+80.57%($87.50)
|
$3,883,402,239
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
-6.74% (-5.79M)
|
-0.29%
|
|
|
|
Alphabet Inc, CL-C
|
3.56%
|
25,239,060
|
$139.65
|
+148.16%($346.56)
|
$3,524,622,109
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
|
|
|
|
|
Occidental Petroleum Corp
|
3.50%
|
61,015,226
|
$56.74
|
+4.08%($59.06)
|
$3,462,003,923
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
-10.77% (-7.36M)
|
-0.43%
|
|
|
|
Sanofi ADR
|
3.38%
|
65,019,128
|
$51.34
|
-15.16%($43.56)
|
$3,338,082,032
|
2019 Q3
|
≈ 2.75 years
|
Depositary Receipt
|
|
|
|
|
|
Capital One Financial Corp
|
2.88%
|
21,661,213
|
$131.29
|
+67.16%($219.46)
|
$2,843,900,655
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
+1.52% (+324.6K)
|
+0.04%
|
|
|
|
MetLife Inc
|
2.83%
|
39,803,442
|
$70.28
|
+37.59%($96.70)
|
$2,797,385,904
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
+0.12% (+46.3K)
|
+0%
|
|
|
|
Cigna Corp
|
2.68%
|
11,051,672
|
$239.61
|
+13.64%($272.28)
|
$2,648,091,128
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
|
|
|
|
|
GlaxoSmithKline PLC ADR
|
2.61%
|
47,383,017.6
|
$54.45
|
-6.20%($51.08)
|
$2,580,005,308
|
2019 Q3
|
≈ 2.75 years
|
Depositary Receipt
|
|
|
|
|
|
FedEx Corp
|
2.54%
|
10,874,177
|
$231.39
|
+38.81%($321.19)
|
$2,516,175,816
|
2019 Q3
|
≈ 2.75 years
|
Common Stock
|
+4.21% (+439.4K)
|
+0.1%
|
|
Completely sold out
2 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Hess Corp
|
-6,588,763
|
-0.5%
|
2019 Q3
|
≈ 2.50 years
|
|
|
|
Halliburton Company
|
-6,548,867
|
-0.15%
|
2019 Q3
|
≈ 2.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.